|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0350 USD | -53.95% |
|
-.--% | +18.64% |
| 05-25 | Ovation Science Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 04-30 | Ovation Science Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
Revenues | 225K | 138K | 61.93K | 113K | 67.89K | ||||
Total Revenues | 225K | 138K | 61.93K | 113K | 67.89K | ||||
Cost of Goods Sold, Total | 883K | 4.05K | 18.67K | 27.5K | 28.09K | ||||
Gross Profit | -658K | 134K | 43.26K | 85.72K | 39.8K | ||||
Selling General & Admin Expenses, Total | 775K | 807K | 699K | 550K | 570K | ||||
Provision for Bad Debts | - | 52 | 61.29K | - | - | ||||
Stock-Based Compensation (IS) | - | - | 37.7K | - | 68.46K | ||||
R&D Expenses | 83.07K | 65.27K | 8.79K | 12.53K | - | ||||
Depreciation & Amortization - (IS) | 8.02K | 6.73K | 3.24K | 2.12K | - | ||||
Other Operating Expenses, Total | 866K | 880K | 811K | 565K | 638K | ||||
Operating Income | -1.52M | -745K | -767K | -479K | -598K | ||||
Interest Expense, Total | - | -588 | -31.08K | -49.93K | -50.36K | ||||
Interest And Investment Income | 4.72K | 3 | - | - | - | ||||
Net Interest Expenses | 4.72K | -585 | -31.08K | -49.93K | -50.36K | ||||
Currency Exchange Gains (Loss) | -1.93K | -4.17K | 343 | -266 | - | ||||
Other Non Operating Income (Expenses) | -130K | -43.88K | -30.76K | 73.04K | 17.28K | ||||
EBT, Excl. Unusual Items | -1.65M | -794K | -829K | -456K | -631K | ||||
Asset Writedown | -742K | - | - | - | - | ||||
Other Unusual Items | - | - | 15.6K | - | - | ||||
EBT, Incl. Unusual Items | -2.39M | -794K | -813K | -456K | -631K | ||||
Earnings From Continuing Operations | -2.39M | -794K | -813K | -456K | -631K | ||||
Net Income to Company | -2.39M | -794K | -813K | -456K | -631K | ||||
Net Income - (IS) | -2.39M | -794K | -813K | -456K | -631K | ||||
Net Income to Common Incl Extra Items | -2.39M | -794K | -813K | -456K | -631K | ||||
Net Income to Common Excl. Extra Items | -2.39M | -794K | -813K | -456K | -631K | ||||
Per Share Items | |||||||||
Net EPS - Basic | -0.08 | -0.03 | -0.03 | -0.01 | -0.02 | ||||
Basic EPS - Continuing Operations | -0.08 | -0.03 | -0.03 | -0.01 | -0.02 | ||||
Basic Weighted Average Shares Outstanding | 29.37M | 29.37M | 30.32M | 34.98M | 35.6M | ||||
Net EPS - Diluted | -0.08 | -0.03 | -0.03 | -0.01 | -0.02 | ||||
Diluted EPS - Continuing Operations | -0.08 | -0.03 | -0.03 | -0.01 | -0.02 | ||||
Diluted Weighted Average Shares Outstanding | 29.37M | 29.37M | 30.32M | 34.98M | 35.6M | ||||
Normalized Basic EPS | -0.04 | -0.02 | -0.02 | -0.01 | -0.01 | ||||
Normalized Diluted EPS | -0.04 | -0.02 | -0.02 | -0.01 | -0.01 | ||||
Supplemental Items | |||||||||
EBITDA | -1.52M | -739K | -764K | -477K | -596K | ||||
EBITA | -1.52M | -745K | -767K | -479K | -598K | ||||
EBIT | -1.52M | -745K | -767K | -479K | -598K | ||||
EBITDAR | -1.49M | -695K | -619K | -380K | - | ||||
Total Revenues (As Reported) | 225K | 138K | 61.93K | 113K | 67.89K | ||||
Normalized Net Income | -1.03M | -496K | -518K | -285K | -395K | ||||
Interest on Long-Term Debt | - | 165 | 13.71K | 24.3K | 19.81K | ||||
Supplemental Operating Expense Items | |||||||||
Advertising Expense | 33.72K | 19.93K | 14.13K | 3.86K | 1.76K | ||||
Selling and Marketing Expenses | 33.72K | 19.93K | 14.13K | 3.86K | 1.76K | ||||
General and Administrative Expenses | 741K | 788K | 685K | 546K | 568K | ||||
Research And Development Expense From Footnotes | 83.07K | 65.27K | 8.79K | 12.53K | - | ||||
Net Rental Expense, Total | 24K | 44.13K | 145K | 97.22K | - | ||||
Imputed Operating Lease Interest Expense | - | - | 308K | 168K | - | ||||
Imputed Operating Lease Depreciation | - | - | -163K | -71.23K | - | ||||
Stock-Based Comp., Other (Total) | - | - | 37.7K | - | 68.46K | ||||
Total Stock-Based Compensation | - | - | 37.7K | - | 68.46K |
- Stock Market
- Stocks
- OVAT Stock
- OVATF Stock
- Financials Ovation Science Inc.
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
















